Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1994 Apr;32(4):1115–1118. doi: 10.1128/jcm.32.4.1115-1118.1994

Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.

L Millon 1, A Manteaux 1, G Reboux 1, C Drobacheff 1, M Monod 1, T Barale 1, Y Michel-Briand 1
PMCID: PMC267201  PMID: 8027327

Abstract

Thirty human immunodeficiency virus-positive patients carrying Candida albicans in their oropharynx were treated with fluconazole and were monitored for 90 to 570 days. Fluconazole-resistant C. albicans (MIC, > 32 micrograms/ml) appeared only in seven patients and only after 90 days of treatment corresponding to a total dose of more than 10 g. Resistance was not associated with resistance to other azole derivatives. Susceptible and resistant strains from each patient had the same genotype (as defined by electrophoretic karyotype and restriction fragment length polymorphism). Thus, the resistant strains were selected by the antimycotic treatment from the susceptible strain present in each case.

Full text

PDF
1115

Images in this article

1117Image
on p.1117

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blumberg H. M., Hendershot E. F., Lott T. J. Persistence of the same Candida albicans strain despite fluconazole therapy. Documentation by pulsed-field gel electrophoresis. Diagn Microbiol Infect Dis. 1992 Aug;15(6):545–547. doi: 10.1016/0732-8893(92)90106-4. [DOI] [PubMed] [Google Scholar]
  2. Chave J. P., Cajot A., Bille J., Glauser M. P. Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study. J Infect Dis. 1989 Apr;159(4):806–807. doi: 10.1093/infdis/159.4.806. [DOI] [PubMed] [Google Scholar]
  3. De Wit S., Urbain D., Rahir F., Weerts D., Clumeck N. Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. Eur J Clin Microbiol Infect Dis. 1991 Jun;10(6):503–505. doi: 10.1007/BF01963937. [DOI] [PubMed] [Google Scholar]
  4. De Wit S., Weerts D., Goossens H., Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet. 1989 Apr 8;1(8641):746–748. doi: 10.1016/s0140-6736(89)92572-5. [DOI] [PubMed] [Google Scholar]
  5. Druetta A., Freydiere A., Guinet R., Gille Y. Evaluation of five commercial antifungal susceptibility testing systems. Eur J Clin Microbiol Infect Dis. 1993 May;12(5):336–342. doi: 10.1007/BF01964429. [DOI] [PubMed] [Google Scholar]
  6. Dupont B., Drouhet E. Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients. J Med Vet Mycol. 1988 Feb;26(1):67–71. doi: 10.1080/02681218880000081. [DOI] [PubMed] [Google Scholar]
  7. Dupouy-Camet J., Paugam A., Tourte-Schaefer C. Yeasts susceptibility testing. Lancet. 1991 Aug 10;338(8763):383–383. doi: 10.1016/0140-6736(91)90514-p. [DOI] [PubMed] [Google Scholar]
  8. Fox R., Neal K. R., Leen C. L., Ellis M. E., Mandal B. K. Fluconazole resistant candida in AIDS. J Infect. 1991 Mar;22(2):201–204. doi: 10.1016/0163-4453(91)91767-r. [DOI] [PubMed] [Google Scholar]
  9. Kitchen V. S., Savage M., Harris J. R. Candida albicans resistance in AIDS. J Infect. 1991 Mar;22(2):204–205. doi: 10.1016/0163-4453(91)91789-z. [DOI] [PubMed] [Google Scholar]
  10. Magee B. B., D'Souza T. M., Magee P. T. Strain and species identification by restriction fragment length polymorphisms in the ribosomal DNA repeat of Candida species. J Bacteriol. 1987 Apr;169(4):1639–1643. doi: 10.1128/jb.169.4.1639-1643.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Magee P. T., Bowdin L., Staudinger J. Comparison of molecular typing methods for Candida albicans. J Clin Microbiol. 1992 Oct;30(10):2674–2679. doi: 10.1128/jcm.30.10.2674-2679.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Merz W. G. Candida albicans strain delineation. Clin Microbiol Rev. 1990 Oct;3(4):321–334. doi: 10.1128/cmr.3.4.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Monod M., Porchet S., Baudraz-Rosselet F., Frenk E. The identification of pathogenic yeast strains by electrophoretic analysis of their chromosomes. J Med Microbiol. 1990 Jun;32(2):123–129. doi: 10.1099/00222615-32-2-123. [DOI] [PubMed] [Google Scholar]
  14. Odds F. C. Resistance of yeasts to azole-derivative antifungals. J Antimicrob Chemother. 1993 Apr;31(4):463–471. doi: 10.1093/jac/31.4.463. [DOI] [PubMed] [Google Scholar]
  15. Pittet D., Monod M., Filthuth I., Frenk E., Suter P. M., Auckenthaler R. Contour-clamped homogeneous electric field gel electrophoresis as a powerful epidemiologic tool in yeast infections. Am J Med. 1991 Sep 16;91(3B):256S–263S. doi: 10.1016/0002-9343(91)90378-b. [DOI] [PubMed] [Google Scholar]
  16. Ryley J. F., Wilson R. G., Barrett-Bee K. J. Azole resistance in Candida albicans. Sabouraudia. 1984;22(1):53–63. [PubMed] [Google Scholar]
  17. Smith D., Boag F., Midgley J., Gazzard B. Fluconazole resistant candida in AIDS. J Infect. 1991 Nov;23(3):345–346. doi: 10.1016/0163-4453(91)93584-y. [DOI] [PubMed] [Google Scholar]
  18. Soll D. R., Galask R., Schmid J., Hanna C., Mac K., Morrow B. Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J Clin Microbiol. 1991 Aug;29(8):1702–1710. doi: 10.1128/jcm.29.8.1702-1710.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vanden Bossche H., Marichal P., Gorrens J., Bellens D., Moereels H., Janssen P. A. Mutation in cytochrome P-450-dependent 14 alpha-demethylase results in decreased affinity for azole antifungals. Biochem Soc Trans. 1990 Feb;18(1):56–59. doi: 10.1042/bst0180056. [DOI] [PubMed] [Google Scholar]
  20. Vazquez J. A., Beckley A., Sobel J. D., Zervos M. J. Comparison of restriction enzyme analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida albicans. J Clin Microbiol. 1991 May;29(5):962–967. doi: 10.1128/jcm.29.5.962-967.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Vazquez J. A., Sanchez V., Dmuchowski C., Dembry L. M., Sobel J. D., Zervos M. J. Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis. 1993 Jul;168(1):195–201. doi: 10.1093/infdis/168.1.195. [DOI] [PubMed] [Google Scholar]
  22. Watson P. F., Rose M. E., Kelly S. L. Isolation and analysis of ketoconazole resistant mutants of Saccharomyces cerevisiae. J Med Vet Mycol. 1988 Jun;26(3):153–162. doi: 10.1080/02681218880000231. [DOI] [PubMed] [Google Scholar]
  23. Welch K., Finkbeiner W., Alpers C. E., Blumenfeld W., Davis R. L., Smuckler E. A., Beckstead J. H. Autopsy findings in the acquired immune deficiency syndrome. JAMA. 1984 Sep 7;252(9):1152–1159. [PubMed] [Google Scholar]
  24. Willocks L., Leen C. L., Brettle R. P., Urquhart D., Russell T. B., Milne L. J. Fluconazole resistance in AIDS patients. J Antimicrob Chemother. 1991 Dec;28(6):937–939. doi: 10.1093/jac/28.6.937. [DOI] [PubMed] [Google Scholar]
  25. vanden Bossche H., Marichal P., Odds F. C., Le Jeune L., Coene M. C. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother. 1992 Dec;36(12):2602–2610. doi: 10.1128/aac.36.12.2602. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES